Standard BioTools (LAB) Provides Preliminary Fourth Quarter 2022 Revenue and Business Update

Go back to Standard BioTools (LAB) Provides Preliminary Fourth Quarter 2022 Revenue and Business Update
Labranche & Co (NASDAQ: LAB) Delayed: 0.73 -0.01 (1.35%)
Previous Close $0.74    52 Week High $4.47 
Open $0.74    52 Week Low $3.02 
Day High $0.77    P/E N/A 
Day Low $0.70    EPS $-1.56 
Volume 35,131,285